Compare IPXL to:
Real-Time: 11.16 -0.19 (-1.67%) 2:28pm ET
| Last Trade: | 11.19 |
|---|---|
| Trade Time: | 2:13pm ET |
| Change: | |
| Prev Close: | 11.35 |
| Open: | 11.31 |
| Bid: | 11.15 x 2900 |
| Ask: | 11.19 x 400 |
| 1y Target Est: | 12.50 |
| Day's Range: | 11.11 - 11.41 |
|---|---|
| 52wk Range: | 3.00 - 11.64 |
| Volume: | 390,865 |
| Avg Vol (3m): | 403,271 |
| Market Cap: | 692.37M |
| P/E (ttm): | 28.77 |
| EPS (ttm): | 0.39 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | Global Pharmaceuticals Awards Grant to Myasthenia Gravis AllianceBusiness Wire |
| Fri, Nov 20 | Impax Laboratories Drives Stronger Performance with IBM Business AnalyticsPR Newswire |
| Tue, Nov 10 | Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare ConferenceBusiness Wire |
| Tue, Nov 10 | IMPAX LABORATORIES INC FinancialsEDGAR Online Financials |
| Fri, Nov 6 | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For InvestorsWall Street Transcript |
| Thu, Nov 5 | [$$] Should You Buy It? Impax Labsat RealMoney by TheStreet.com |
| Wed, Nov 4 | IMPAX LABORATORIES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Wed, Nov 4 | New Star Analyst Rankings for Impax Laboratories, Inc.StarMine |
| Tue, Nov 3 | Impax swings to Q3 profitat bizjournals.com |
| Tue, Nov 3 | Impax Laboratories Earnings Call scheduled for 11:00 am ET todayCCBN |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.